BRIEF

on HBM Healthcare Investments AG (ETR:CH001262)

HBM Healthcare Reports February 2026 Financial Performance

HBM Healthcare Investments AG released its key financial figures for February 2026. The Net Asset Value (NAV) per share stands at CHF 272.51, marking a monthly decline of 2.7%. Year-to-date, the NAV shows a 14.6% increase. However, the calendar year-to-date performance records a slight decrease of 3.0%.

The company's share price is CHF 220.00 as of mid-February, which is down by 8.3% for the month. Despite this, the share price has increased by 25.7% since the start of the fiscal year. Calendar year-to-date, the share price has seen a marginal decline of 2.9%.

Total net assets are reported at CHF 1,806 million. These figures highlight the mixed performance seen in the healthcare investment sector during this period.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all HBM Healthcare Investments AG news